Sources: US News
South Korea signs an agreement to buy an additional 400,000 doses of Pfizer's Paxlovid COVID-19 drug. 2022-01-5
Bahrain authorizes the emergency use of Pfizer's anti-viral oral drug Paxlovid for adults over the age of 18 years. 2022-01-1
The Food and Drug Administration grants emergency use authorization for Pfizer's antiviral COVID-19 oral pill named Paxlovid for at-risk people over the age of 12 years, becoming the first at-home oral treatment to be approved by the FDA. 2021-12-22
South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine. 2021-08-13
Israeli Prime Minister Naftali Bennett announces that a deal has been reached with Pfizer CEO Albert Bourla, which would see a new shipment of vaccines delivered on August 1. 2021-07-11
Ukraine signs a deal with Pfizer to supply 10 million doses of the Pfizer–BioNTech vaccine. 2021-04-6
The government announces a deal with Pfizer to receive 14 million doses of its COVID-19 vaccine by June, and a total of 99 million doses by the end of the year. 2021-03-8
The Ministry of Public Health approves the authorization of the Pfizer-BioNTech vaccine for emergency use in Qatar. 2020-12-20
Pfizer announces that it has submitted their vaccine for approval in India. 2020-12-5
The United Kingdom approves the BNT162b2 vaccine made by Pfizer and BioNTech for widespread use, becoming the first country in the world to approve the vaccine. The government states that the vaccine will be rolled out early next week. 2020-12-2